| Health / Medical Topics |
Zoledronic Acid Anhydrous
Anhydrous form of a synthetic imidazole third generation bisphosphonate analog of pyrophosphate with antiresorptive activity. Zoledronate binds to hydroxyapatite crystals in the bone matrix and inhibits farnesyl pyrophosphate (diphosphate) synthase, thereby preventing protein prenylation within the mevalonate pathway. This leads to the loss of downstream metabolites essential for osteoclast function, leading to the induction of apoptosis and eventually, osteoclast-cell death. By preventing osteoclast-mediated bone resorption, zoledronate decreases bone turnover and stabilizes the bone matrix. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to treat patients with hypercalcemia (high blood levels of calcium) caused by cancer. It is also used together with…
The trisodium salt form of zoledronate, a synthetic imidazole, third generation bisphosphonate analog of pyrophosphate with antiresorptive activity. Zoledronate binds to hydroxyapatite…
The disodium salt form of zoledronate, a synthetic imidazole, third generation bisphosphonate analog of pyrophosphate with antiresorptive activity. Zoledronate binds to hydroxyapatite…
A drug used to treat patients with hypercalcemia (high blood levels of calcium) caused by cancer. It is also used together with…
A nonpeptide angiotensin II receptor antagonist with antihypertensive activity. Zolasartan selectively competes with angiotensin II for the binding of the angiotensin II…
A drug used to treat prostate cancer and to relieve the symptoms of advanced breast cancer. It is also used to treat…
